Treatment of chronic heart failure in the 21st century: A new era of biomedical engineering has come

Chronic heart failure (CHF) is a challenging burden on public health. Therapeutic strategies for CHF have developed rapidly in the past decades from conventional medical therapy, which mainly includes administration of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chun-Song, Wu, Qing-Hua, Hu, Da-Yi, Tkebuchava, Tengiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association 2018
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656907/
https://www.ncbi.nlm.nih.gov/pubmed/31367696
http://dx.doi.org/10.1016/j.cdtm.2018.08.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656907/
https://www.ncbi.nlm.nih.gov/pubmed/31367696
http://dx.doi.org/10.1016/j.cdtm.2018.08.005

Ejemplares similares